Standard Biotools Inc (LAB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 174,432 | 106,340 | 97,948 | 130,581 | 138,144 |
| Cost of Goods | 90,170 | 55,890 | 60,897 | 61,208 | 54,818 |
| Gross Profit | 84,262 | 50,450 | 37,051 | 69,373 | 83,326 |
| Operating Expenses | 259,668 | 127,940 | 154,153 | 137,040 | 135,180 |
| Operating Income | -175,236 | -76,600 | -116,205 | -67,459 | -51,036 |
| Interest Expense | 3,316 | 4,567 | 4,331 | 3,823 | 3,572 |
| Other Income | 40,240 | 6,963 | -72,392 | 7,622 | 507 |
| Pre-tax Income | -138,312 | -74,204 | -192,928 | -63,660 | -54,101 |
| Income Tax | 573 | 452 | -2,830 | -4,423 | -1,081 |
| Net Income Continuous | -138,885 | -74,656 | -190,098 | -59,237 | -53,020 |
| Net Income | $-138,885 | $-74,656 | $-190,098 | $-59,237 | $-53,020 |
| EPS Basic Total Ops | -0.52 | -0.94 | -2.43 | -0.78 | -0.74 |
| EPS Basic Continuous Ops | -0.39 | -0.94 | -2.43 | -0.78 | -0.74 |
| EPS Diluted Total Ops | -0.52 | -0.94 | -2.43 | -0.78 | -0.74 |
| EPS Diluted Continuous Ops | -0.39 | -0.94 | -2.43 | -0.78 | -0.74 |
| EPS Diluted Before Non-Recurring Items | -0.43 | -0.58 | -1.23 | -0.56 | -0.50 |
| EBITDA(a) | $-165,810 | $-62,681 | $-101,852 | $-51,264 | $-32,550 |